Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pro-inflammatory protein contributes to Crohn’s disease

04.02.2005


A pro-inflammatory protein activated by bacteria in the colon plays a key role in the development of experimental colitis in mice – a mouse-version of human Crohn’s disease – according to research by scientists at the University of California, San Diego (UCSD) School of Medicine.

The study, published in the February 4, 2005 issue of the journal Science, identified interleukin-1Beta (IL-1â) as a major cause of severe inflammation in the mouse model of Crohn’s disease, which is a painful, chronic and little-understood inflammatory bowel disease (IBD) in humans, affecting more than 500,000 Americans. These individuals are considered at high risk for colon cancer.

The identification of IL-1â offers a potential target for drug development, said the study’s senior author, Michael Karin, Ph.D., UCSD professor of pharmacology and an American Cancer Society Research Professor. Although there is currently an IL-1â inhibitor on the market for other, non-Crohn’s chronic inflammatory conditions such as rheumatoid arthritis, this drug is not a very potent IL-1â inhibitor. "Now that we’ve identified IL-1â as an important target for Crohn’s disease therapy, we hope that a better, more effective IL-1â inhibiting drug can be developed for testing its efficacy in these patients," Karin said.



Crohn’s disease is thought to involve an interaction between a genetic defect and environmental factors such as bacterial infections that trigger the disorder. Recently, scientists identified mutations in a gene called NOD2 as leading to 50 percent of Crohn’s cases in patients of Northern European descent, but they haven’t known just how NOD2 causes the severe inflammation associated with the disorder. An intracellular sensor for bacterial infection, normal NOD2 activates a protein called nuclear factor-kappaB (NF-kB), which is involved in the immune system’s rapid response to bacterial infection. It has been observed that many of the drugs currently used to help Crohn’s disease patients may also act as weak and nonspecific NF-kB inhibitors in addition to having many other activities. Given the new results in the study, drugs that are more potent and more specific inhibitors of NF-kB also need to be tested for their therapeutic effects on Crohn’s disease patients.

Karin, who has conducted extensive research over the years on NF-kB and related genes, developed mice with mutant NOD2, that is identical to what is found in many Crohn’s disease patients, and then introduced a bacterial infection into the walls of their colons. One-third of the mice bearing the mutation developed very severe colon inflammation and died, while the surviving animals had large lesions in their colons and lost a considerable amount of weight. His research team found that the mice bearing the NOD2 mutation also had markedly high levels of active NF-kB in the inflammatory cells (macrophages) that were present within their colons. Interestingly these mice also had high levels of mature IL-1â, a pro-inflammatory protein.

"The unique thing about IL-1â is that it is first made as a larger precursor that accumulates within the inflammatory cells but is usually very poorly secreted," Karin said, "only under certain circumstances, an enzyme called IL1 converting enzyme (ICE) is activated, the IL-1â precursors, whose synthesis is stimulated by NF-kB, are cleaved and the mature protein can be secreted. Therefore finding high levels of IL-1â secretion in the mutant mice suggested that in addition to activating the NF-kB, that mutant NOD2 also stimulated the processing of the IL-1â precursor into its mature form."

The Karin team then gave an IL-1â inhibitor to mice and it abolished the experimental colitis (Crohn’s Disease) in the mutant mice; none of the animals died and inflammation was considerably reduced.

Sue Pondrom | EurekAlert!
Further information:
http://www.ucsd.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Physicists discover mechanism behind granular capillary effect

24.05.2017 | Physics and Astronomy

Measured for the first time: Direction of light waves changed by quantum effect

24.05.2017 | Physics and Astronomy

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>